Skip to main content
Category

Champions

Augie’s Quest to Cure ALS granted $159,122 to the ALS Therapy Development Institute through Cure ALS Golf Classic

By Champions No Comments

August 26, 2022: Augie’s Quest to Cure ALS granted $159,122 to the ALS Therapy Development Institute today. Special thanks to Scott Cameron, recipient of the Phil Green award and chairman of the Cure ALS Golf Classic, for playing a key role in raising these research funds, which are granted in his honor. Scott is a member of the Augie’s Quest to Cure ALS Leadership Council and works tirelessly to find treatments and a cure in honor of his late father, Sandy, who had ALS.

“Thank you to Scott Cameron for sharing our Quest to find a cure for ALS, and his continued leadership,” said Augie Nieto, Chairman of Augie’s Quest to Cure ALS.  “With warriors like Scott and his family, we’re closer than ever to a cure.  We’re proud to provide these funds to ALS TDI in honor of the great volunteer work being done by Scott Cameron ,Phil Green and the dedicated event committee.”

These critical funds support the Augie’s Quest Translational Research Center at ALS TDI which was established to better understand the mechanisms of how amyotrophic lateral sclerosis (ALS) affects the body and use the knowledge to develop new, more effective treatments for the disease. These funds are part of a larger $5.8 million grant from Augie’s Quest to ALS TDI through 2024 that was established to fund the discovery of new candidate drugs to slow, stop, or even reverse ALS disease progression.

The Cure ALS Golf Classic has raised more than $1 million for ALS research. 

Augie's Quest logo

ALS Community Comes Together in Unprecedented Fashion To Urge Congress To Pass Critical Access To Disability Benefits Bill

By Champions

FOR IMMEDIATE RELEASE

Sept. 15, 2020

 

ALS Community Comes Together in Unprecedented Fashion To Urge Congress To Pass Critical Access To Disability Benefits Bill

Twenty ALS Advocate Groups Coordinate to Attain More than 360 Co-Sponsors

in both the House and Senate

 

WASHINGTON – This week, twenty ALS advocacy groups collaborated together to thank the more than 360 Congressional members from across the aisle who have co-sponsored H.R. 1407 and S. 578, which would extend Social Security Disability Insurance (SSDI) benefits for patients living with ALS. The ALS community is now calling on Congress for swift passage of H.R. 1407 and S. 578.

 

The legislation was introduced 19 months ago, but the coordinated campaign among local, regional and national ALS organizations drove progress in the past six months to attain Congressional support. The passing of the bill will provide ALS patients and their loved ones access to SSDI benefits without having to wait five months from the time of diagnosis – an eternity within the two-to-five-year life expectancy of the disease.

 

The effort was sustained by members of the ALS community who worked with Congress, including:

 

  • ALS Hope Foundation
  • ALS ONE
  • Answer ALS
  • Augie’s Quest to Cure ALS
  • Brigance Brigade
  • Compassionate Care ALS
  • Every90Minutes Foundation
  • Everything ALS
  • Hope Loves Company
  • I AM ALS
  • Joe Martin ALS Foundation
  • Les Turner ALS Foundation
  • A Life Story Foundation
  • Live Like Lou
  • Muscular Dystrophy Association
  • The Northeast ALS Consortium (NEALS)
  • The Project ALS Therapeutics Core at Columbia
  • Team Stevens Nation
  • Team Gleason
  • Your ALS Guide

 

 

The ALS community is grateful to each Representative and Senator supporting H.R. 1407 and S.578 during this critical moment for our nation. ALS is an enormous financial burden and it is crucial those living with ALS and their families have as much support as possible. Now, more than ever, it’s imperative Congress passes H.R. 1407 and S. 578 and sends it to the President’s desk for his signature.

 

About ALS

ALS is a disease that attacks cells in the body that control movement. It makes the brain stop talking to the muscles, causing increased paralysis over time. Ultimately, ALS patients become prisoners within their own bodies: unable to eat, talk, breathe or move on their own. Their mind, however, often remains sharp so they are aware of what’s happening to them. ALS will affect 1 in 300 people in our lifetimes, and patients usually have no more than two to five years to live following diagnosis.

Augie's Quest logo

Acquisition of Anelixis Therapeutics Fuels Hopes for ALS

By Champions

Acquisition of Anelixis Therapeutics Fuels Hopes for ALS

 

FOR IMMEDIATE RELEASE

ORANGE COUNTY, Calif. SEPTEMBER 15, 2020 Anelixis Therapeutics, the for-profit clinical-stage development company that advanced the drug AT-1501 to clinical trial, announced on Monday, September 14, that they have been acquired by Novus Therapeutics. Through this acquisition, AT-1501 is expected to advance to the next stage of clinical development, a phase 2 trial in ALS.

Augie Nieto, the-co-founder and Chairman of Augie’s Quest to Cure ALS also serves as Chairman of the ALS Therapy Development Institute, who invented AT-1501.  Augie was also a founding board member of Anelixis.

“When we started Augie’s Quest to Cure ALS in 2005, we knew our best chance of fueling a cure and treatments for this devastating disease was to find the best scientific partner – which we did in ALS TDI,” said Augie Nieto.  “Solid leadership drives success, and we couldn’t be more excited about the acquisition of Anelixis by Novus Therapeutics.  We need stronger treatment options for ALS, and I’m confident this is a critical step to reach that goal,” he added.

AT-1501 is an investigational antibody that targets the CD40 ligand (CD40L), a protein present at the surface of some white blood cells that is involved in inflammation. In ALS, blocking CD40L activation decreases inflammatory responses implicating CD40L in neurodegeneration.

AT-1501 was invented by the ALS Therapy Development Institute with funding from Augie’s Quest to Cure ALS, and in 2019, Anelixis Therapeutics successfully completed phase 1 clinical trials for AT-1501 as a treatment for ALS. The study, involving both healthy volunteers and participants with ALS, showed that AT-1501 was well tolerated at all doses tested and that the pharmacokinetic properties of AT-1501 were typical for an IgG1 antibody therapeutic.

AT-1501 is being developed by Novus Therapeutics as a potential treatment in renal transplantation, islet cell transplantation, autoimmune nephritis, and ALS . ALS will be the first of these indications to begin enrolling for Phase 2 trials, and enrollment is expected to begin by the end of 2020.

ALS TDI’s CEO, Steve Perrin, PhD stated, “The partnership between ALS TDI and Anelixis to move AT-1501 from preclinical to clinical development has been very exciting. This unique business relationship truly demonstrates the ability of a non-profit to leverage philanthropic support, like that from Augie’s Quest to Cure ALS,  to move a promising treatment into clinical trials. As we discover more potential treatments for ALS, we will lean into these experiences as we look to advance new leads into human clinical testing.”

Steve Perrin will serve as President and Chief Scientific Officer of Novus Therapeutics, and also serve on the board.  Walter Ogier, the Chairman of the Board of Anelixis, will take the second board seat.  “I was so impressed with Walter’s performance as Chairman of Anelixis, that I believed it was critical that Steve and Walter continue to serve on the board due to their decades of experience,” added Nieto.

AT-1501 is the first potential treatment to be invented at ALS TDI and successfully advanced through a Phase 1 clinical study. However, scientists at ALS TDI are continuing to work to find more potential treatments for people with ALS. With continued funding, ALS TDI hopes to develop more promising treatments that can be brought through trial and eventually become available for people with ALS.  Augie’s Quest to Cure ALS is committed to continue to fund the important science being done at ALS TDI.

About Augie’s Quest to Cure ALS

 Augie’s Quest to Cure ALS is dedicated to changing the experience of people living with ALS. We raise the funds and awareness urgently needed to advance cutting-edge research, fast-track effective treatments, and ultimately, find a cure for this devastating disease. Augie’s Quest was founded in 2005 by Augie Nieto, the successful fitness industry mogul behind Lifecycle and Life Fitness and whose life story was recently chronicled in the award-winning film, Augie. With Augie’s Quest, ALS doesn’t stand a fighting chance. Because ALS isn’t incurable, it’s only underfunded. Please join our quest at www.augiesquest.org.

About AT-1501

AT-1501 is a humanized IgG1 anti-CD40L antibody with high affinity for CD40L, a well-validated target with broad therapeutic potential. The CD40/CD40L pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation. In a Phase 1 safety study of healthy volunteers and patients with ALS, AT-1501 was well tolerated at all doses tested.

 

About Anelixis Therapeutics

 Anelixis Therapeutics, Inc. was a clinical stage, privately held biotechnology company developing treatments for patients with neurodegenerative disease, people requiring an organ or cell based transplant, as well as people with an autoimmune disease. Since its founding in 2015, Anelixis Therapeutics has optimized and validated a cGMP manufacturing process for AT-1501, confirmed exceptional activity in preclinical disease models, demonstrated safety and tolerability in humans

The development of AT-1501 has been funded with support from The ALS Therapy Development Institute, Augie’s Quest to Cure ALS, The ALS Association, ALS One, ALS Finding a Cure, and The Congressionally Directed Medical Research Program. Anelixis also conducted several private placement rounds including a round led by  Noble Capital Markets, Inc. (Noble), an investment bank headquartered in Boca Raton Florida, who acted as the exclusive placement agent in a private placement financing round, and a financing round was also led by the Biotechnology Value Fund, L.P. and other affiliates of BVF Partners L.P. (“BVF”).

For more information, please visit the company’s website at www.AnelixisTherapeutics.com.

 

 

 

 

 

 

 

 

 

Dancing at the bash

The Good Days Will Always Outnumber the Bad

By Champions

A Veteran Talks

“Hey kid, the good days will always outnumber the bad,” he said to me with a kind smile and wink. We were sitting side by side in the infusion center at Massachusetts General Hospital receiving therapy back in early 2002. Bill and I were on the same treatment rotation and had become friends. He had been front and center during the Cuban missile crisis in the Navy. I was currently on active duty as a Navy Nurse in CT. He was receiving the treatment appropriate for his neuro muscular condition. I was receiving it on the slim chance it would help, since one of my lab values was unusual when all other evidence pointed directly to the inescapable ALS. I was 26 years old, scared about the future, sitting next to my fellow veteran, and found his words were of great comfort to me.

Eighteen years later, I find that the good days have always outnumbered the bad and I suspect it will continue to be this way. The bad days have included the shattered dream of having children of my own as my siblings and friends continued “normal life.” The bad days also included the end of a young marriage in a bitter divorce. But, as you know, ALS is relentless in breaking bodies and hearts.

Today, we all find ourselves in unprecedented, turbulent times. This can be very unnerving, especially, when combined with ALS. My partner and I went into strict isolation in mid-March and spent three months together 24/7 as he was my only caregiver. We struggled through the social isolation, my guilt about depending completely on him and figured out how to settle into a new type of lifestyle. Our days now have a simpler rhythm. Watching flowers blossom is a big treat! The garage is not for my van anymore. It is set up for socializing with neighbors and family at a safe distance complete with a screen tent, carpet, lawn chairs and flower pots to line the entrance!

During these turbulent, changing times, I have some good news to share. My partner, Leif, and I got engaged a few weeks ago and are planning a very small ceremony October 3rd! WHAT??  Who marries a 44 year old woman who has ALS? Evidently, Leif does. We have been living together for eight years and he figured if we could be together 24/7 for three months and still like each other, we might as well give marriage a shot.

I pray that as we all find new paths forward, excavating our former lives, positive things will surface. I am pleased to learn that ALS clinical trials have used the past few months to pivot how trials are run. They are now maximizing the use of video appointments to gather information and reduce in person visits. The field has also shifted to investigating breathing measurements that can be taken at home and doing safety labs locally. These changes bring the possibility of including more people in ALS trials by reducing some of the barriers.

We will all continue to have bad days. Life is just like that. My wish for you is that your good days always outnumber the bad. Keep your heads up and seek out the positive.

Sending my love from NH,

Ellen Corindia

3/13/15
Los Angeles, CA
ALS.net
BASH for Augie’s Quest
Photo Credit: Marvin Steindler/Steve Cohn Photography
© 2015 Steve Cohn Photography
www.stevecohnphotography.com
(310) 277-2054

Augie's Quest logo

COVID-19 Resources for the ALS Community

By Champions

If you or someone you know has ALS and is currently experiencing symptoms of COVID-19, please contact your healthcare provider immediately.  

With the recent assignation of COVID-19 as a pandemic by the World Health Organization, we are sharing pertinent information with the ALS community to understand the risks and impact of SARS-CoV2. Please note that per the CDC, this is a rapidly evolving situation, and the CDC will continue to share updates daily.

While there is currently no evidence to show that patients with ALS are uniquely sensitive to the virus, individuals with respiratory health issues, chronic medical conditions such as heart disease, diabetes or lung disease, and those who are elderly may be at a higher risk for experiencing COVID-19 severely.

Prevention & Management: 

In addition to following the CDC recommendations for the prevention and management of COVID-19, we recommend asking your ALS clinic care team whether they recommend an in person or tele-visit. You may also find the Les Turner ALS Foundation’s care recommendations for respiratory issues helpful.

The ALS Association has published  “ Tips to Help the ALS Community Plan Ahead During the COVID-19 Pandemic”  developed for people with ALS and their families, to help them advocate effectively with healthcare providers, healthcare facilities, emergency medical technicians and medical transport systems to ensure fair and appropriate treatment during the COVID crisis.

Information Related to Clinical Trials:

If you are currently participating in a clinical trial, contact your trial care team to determine if there are any changes to protocol or timeline.

In an Emergency Situation:

If you are in need of assistance from an emergency medical technician (EMT) please reference this document from I AM ALS for helpful information to provide to them and emergency room staff regarding additional precautions to take when caring for ALS patients.

The CDC and other health professionals are learning more about COVID-19 every day. While the possibility of contracting a contagious disease is scary, it is important to stay calm and follow recommended prevention and management strategies. Please continue to check the CDC’s website for the most up to date information about COVID-19 in the US.

Support Resources

Augie’s Quest, Team Gleason, Les Turner ALS Foundation, I AM ALS, LiveLikeLou, Hope Loves Company, The Joe Martin ALS Foundation, The Brigance Brigade Foundation and others across the ALS community are banding together to support ALS families during this time. We have compiled a list of resources that are providing assistance to families with ALS who are affected by COVID-19. 

Financial Assistance & Volunteer Support:

  • The Healthwell Foundation is offering a small grant to help people cover costs related to COVID-19 such as delivery of food, medications, transportation and telehealth visits. Check out the eligibility details here and call (800) 675-8416 to apply over the phone.
  • The Susie Foundation in Connecticut has introduced a Good Neighbors program that will connect families affected by ALS with volunteers who will run 1-2 critical errands for them per week. They are also repurposing their Flex Grant program to provide emergency funding to families who are struggling with unexpected expenses due to the spread of COVID-19. Learn more about their programs and how to apply here
  • The Les Turner ALS Foundation in the Chicagoland area is providing emergency relief funding. Learn more here
  • The LiveLikeLou Foundation has launched the Great LiveLikeLou Outdoor Clean-Up for ALS Families to match ALS Families with Phi Delts to offer volunteer support to ONLY 1) outdoor projects and chores, 2) no personal contact and 3) CDC-allowable interactions.  This is a “one-time” or “occasional” support for ALS Families so that the college students in particular can meet their families’ expectations for support.

Equipment:

  • Your ALS Guide is donating 5,000 FDA-approved surgical masks to people living with ALS, caregivers, and ALS professionals in the United States. People can request masks at Masks for the ALS Community and they will be mailed out within 48 hours.
  • Every 90 Minutes, Team Gleason and Evergreen Circuits are providing ventilator filters from Philips Respironics to ALS patients who are unable to get it through a DME supplier. Click here to apply
  • Team Gleason is continuing to provide all of its services to people living with ALS, with the exception of adventures which have been suspended. Learn about how they may be able to help you and apply for assistance here
  • Acknowledging that there may be a shortage of some supplies, Respiratory Quality Services researched ways to clean your breathing device accessories. You can read them here. Be sure to consult with your Respiratory Therapist on these guidelines.

Veterans:

  • The House Committee on Veterans’ Affairs has helpful information on COVID-19 resources for veterans with ALS here.

Virtual Engagement:

  • Hope Loves Company is going virtual! Check out their site for updates on online activities and their upcoming Pen Pal program for children, teens and adults. 
  • Team Gleason and The Center for Medicare Advocacy will be hosting a webinar to address benefits in the rapidly changing Medicare environment. Stay tuned for the scheduled date.
  • The Brigance Brigade Foundation (BBF) will soon launch the BBF Caregiver Club, which will be a virtual meetup of caregivers of people living with ALS (CALS). The Caregiver Club will encourage CALS to set aside time to practice self-care through guided activities such as art, journaling, meditation, and exercise. Email Amy Mullan at amullan@brigancebrigade.org to learn more and sign up.

Good News:

Know of a resource to support people affected by COVID-19 that we missed? Email us at AQ@augiesquest.org and we will include it once vetted.

Augie’s Quest 15th Annual BASH event returns to San Diego

By Champions

Media Contact:

Shannon K. Shryne, Augie’s Quest

Shannon@augiesquest.org and C: 619.791.5070

 

 

 

FOR IMMEDIATE RELEASE

 Augie’s Quest 15th Annual BASH event returns to San Diego

Nonprofit celebrates fitness industry commitment to finding a cure for ALS

 San Diego, February 7, 2020 – Augie’s Quest to Cure ALS, a nonprofit committed to changing the experience of thousands living with amyotrophic lateral sclerosis (ALS) by fast-tracking effective treatments and an ultimate cure, is celebrating their 15th BASH fundraiser by Rockin’ Through the Ages with the fitness industry on March 20.

Over 800 guests are expected to attend the event, which is held in conjunction with the International Health, Racquet and Sportsclub Association’s (IHRSA) International Tradeshow and Convention. The BASH represents an opportunity for the fitness industry to come together and celebrate advancements in ALS research, while reminding attendees of the critical hope their support offers for those affected by this disease.

“The fitness industry has made Augie’s Quest THEIR quest.  They’re focused on making our world healthier, and this passion for helping people has directly impacted every individual living with ALS,” said Augie Nieto, Co-Founder, Augie’s Quest to Cure ALS. “I’m proud to share the stage at this year’s BASH with the Chief Scientific Officer of the ALS Therapy Development Institute, Fernando Vieira, and fellow ALS Fighter Andrea Lytle Peet to share the incredible work we’re doing with the funds we’ve raised at the BASH.

This event is Presented by IHRSA and sponsored by Orangetheory Fitness, Jenny Craig, Newtown Athletic Club, The Atlantic Club, Zumba Fitness, Stone Creek Club & Spa, Club Automation, UFC Gym, Fitness Formula Clubs, Club Greenwood, Crunch Fitness, Hydromassage, North Castle Partners, Las Vegas Athletic Clubs and Planet Fitness, as well as others. The event will be emcee’d by international Zumba Education Specialist Loretta Bates, with entertainment provided by Australian raised Toby Rand, who is currently starring as a lead, in the hit “Broadway” musical ROCKTOPIA who previously appeared  on the CBS TV show Rockstar: Supernova with Tommy Lee, Jason Newstead, Gilby Clarke and Dave Navarro. The show was seen by over 20 million viewers each week and ended with RAND as runner-up and winning a signed record deal.

Just last month, the ALS Therapy Development Institute announced the naming of the Augie’s Quest Translational Research Center which will help to strengthen its existing and future research efforts by aiming to dissect mechanisms of clinical ALS and use the knowledge to develop new, more powerful drug discovery platforms and facilitate more effective drug development in ALS.

“In recent years, translational research has emerged as an increasingly important component of ALS TDI’s drug discovery,” says Fernando Vieira, Chief Scientific Officer, ALS TDI. “We owe much of our progress and ability to expand this transformative, essential research to Augie’s Quest. And, we are honored to celebrate this impact on our science with this special commendation.”

You can join the quest to end ALS at the 15th annual Bash by visiting augiesquest.org/bash.

About Augie’s Quest to Cure ALS

Augie’s Quest to Cure ALS is a nonprofit committed to changing the experience of people living with ALS by fast-tracking cutting-edge research to advance effective treatments and an ultimate cure. The organization is galvanizing thousands to join this fight, confronting ALS in an entirely new way, and driving innovative research forward, and at an accelerated pace. We are working to bring an exciting treatment, AT-1501, and many others, to market as fast as we can via our research partners at the ALS Therapy Development Institute. Augie’s Quest was co-founded more than a decade ago by Augie Nieto, the successful fitness industry mogul behind Lifecycle and Life Fitness who was diagnosed with ALS in 2005 and whose life story was recently chronicled in the award-winning film, Augie. With Augie’s Quest, ALS doesn’t stand a fighting chance. Because ALS isn’t incurable, it’s only underfunded. Please join our quest at www.augiesquest.org.

 

CKO Kickboxing & Augie’s Quest Join Forces to “Kick Some ALS”

By Champions

New Fundraising Campaign – Including CKO Punchathon — Kicks Off November 1

Los Angeles, November 1, 2019 – CKO Kickboxing members will put on their boxing gloves as part of a new CKO fundraising drive called “Kick Some ALS” to benefit Augie’s Quest to Cure ALS, a nonprofit committed to changing the experience of thousands living with amyotrophic lateral sclerosis (ALS) by fast-tracking effective treatments and an ultimate cure.

The two-week fundraising campaign launches on November 1 and runs through November 15 at CKO Kickboxing locations across the country. During this time period, CKO Kickboxing makes it easy and fun to donate to this important cause. CKO Kickboxing will also host special CKO Punchathons to “Kick some ALS,” a 90-minute, high energy kickboxing workout, with incentives and prizes. One hundred percent of the $25 class fee will benefit Augie’s Quest.

“ALS robs people of everything fitness and exercise provides including strength, muscle fitness, mobility and more,” says Augie Nieto, Co-Founder and Chair of the Board, Augie’s Quest to Cure ALS and fitness industry icon who has lived with an ALS diagnosis for 14 years. “We are incredibly grateful to have CKO Kickboxing as a new national partner, willing to flex its muscle, join with Augie’s Quest and kick some ALS. Together, ALS doesn’t stand a fighting chance.”

Every 90 minutes someone is diagnosed with ALS, a neurodegenerative disease that attacks the very muscles we work so hard to keep strong, flexible and moving. For people with ALS, as the disease progresses, their motor neurons die off, blocking communication between their brain and their muscles. When voluntary muscles begin to shut down, people with ALS lose their ability to walk, speak, and ultimately breathe. Most people with ALS only live 2-5 years after experiencing the first signs of the disease. Currently, there are no known cures or effective treatments for ALS.

But ALS is curable, it’s just underfunded. Today there is new hope like never before. Thanks to support from national corporate partners like CKO Kickboxing, Augie’s Quest to Cure ALS is helping to fast-tracking new treatments and an ultimate cure. Click here to learn more about the Punchathon.

Little Big Town with Augie and Lynne Nieto of Augie's Quest at the 14th annual Tradition of Hope Gala

Award-Winning Little Big Town’s Spectacular Performance is the Highlight of Augie’s Quest to Cure ALS’ 14th Annual Tradition of Hope Gala

By Champions

Event Raises More Than $1.03 Million to End ALS!

Little Big Town with Augie and Lynne Nieto of Augie's Quest at the 14th annual Tradition of Hope Gala

Photo credit BE Studios for Augie’s Quest: The award-winning Little Big Town — Jimi Westbrook, Karen Fairchild, Kimberly Schlapman and Philip Sweet — join alongside actor Jay Mohr and Augie and Lynne Nieto before their performances during the 14th Annual Augie’s Quest to Cure ALS Tradition of Hope Gala at the Montage Hotel in Laguna Beach. The evening’s celebration raised more than $1 million to end ALS, with 500 generous donors and friends coming together to support this urgent cause and honor two special ALS champions and area residents – Larry Green and John Duden (not featured in photo) – with the organization’s signature awards.

LAGUNA BEACH, CA, OCTOBER 11, 2019: The 14th Annual Augie’s Quest to Cure ALS Tradition of Hope Gala at the Montage Hotel, Laguna Beach gathered more than 500 donors, friends, entertainers and businesses to raise the funds and awareness needed to help fast-track effective treatments and an ultimate cure for this devastating disease.

 

Little Big Town rocked the house at the Augie’s Quest 14th Annual Tradition of Hope Gala,” said Augie Nieto, Chief Inspriation Officer and Co-Founder, Augies Quest and Chair of the Board, ALS TDI. “Thanks for joining our Quest to #EndALS and helping us raise more than $1 million tonight!”

 

Additionally, the event was emceed by Actor, Comedian & Best-Selling Author Jay Mohr, whose friend Phil Green (an active member of Augie’s Quest Leadership Council and ALS advocate) is battling the disease. Here, Augie’s Quest also honored two outstanding ALS champions and Orange County residents, presenting Larry Green with its Founders Award, and John Duden with its Courage Award, for their respective personal efforts to help end ALS.

 

“Inspired night with Augie’s Quest to fight ALS,” posted Little Big Town via its Facebook, Twitter and Instagram pages with a photo of the award-winning band prior to their special performance that night. “Thank you, Augie!”

 

ABOUT AUGIE’S QUEST TO CURE ALS

Augie’s Quest to Cure ALS is a nonprofit helmed by local fitness industry titan and Corona Del Mar residents, Augie and Lynne Nieto, who have been taking on this disease for nearly 15 years. Augie was the “Steve Jobs” of the fitness industry, a business icon finding career success building the Life Fitness and Life Cycle brands, ushering in popular work outs and new forms of cardio, and getting the masses to hit the gym. Since their ALS diagnosis, the couple has been on a unique quest, rallying family, friends and the entire fitness industry to fund innovative science, effective treatments and an ultimate cure through their nonprofit, Augie’s Quest to Cure ALS. In collaboration with their research partners at the ALS Therapy Development Institute, they have raised more than $150 million to fund essential research and develop treatments and cures.

Because ALS isn’t an incurable disease; it’s only underfunded. Augie’s Quest tireless work has driven innovative science forward at an accelerated pace–including one of the most promising drug treatments yet and a thriving precision medicine program. The quest for a cure is not yet over, but this incredible community is still fighting to end ALS once and for all. Learn more at www.augiesquest.com.

ALS won’t stop and neither will Augie’s Quest

Augie’s Quest to Cure ALS
PO Box #9886
Denver, CO 80209

T: 949-506-1007
E: AQ@augiesquest.org

Copyright © 2022 Augie's Quest. All Rights Reserved.